Search

Drug discovery involves a crucial step of optimizing molecules with the desired structural groups. In the domain of computer-aided drug discovery, deep learning has emerged as a prominent technique in molecular modeling. Deep generative models, based on deep learning, play a crucial role in generating novel molecules when optimizing molecules. However, many existing molecular generative models have limitations as they solely process input information in a forward way. To overcome this limitation, we propose an improved generative model called BD-CycleGAN, which incorporates BiLSTM (bidirectional long short-term memory) and Mol-CycleGAN (molecular cycle generative adversarial network) to preserve the information of molecular input. To evaluate the proposed model, we assess its performance by analyzing the structural distribution and evaluation matrices of generated molecules in the process of structural transformation. The results demonstrate that the BD-CycleGAN model achieves a higher success rate and exhibits increased diversity in molecular generation. Furthermore, we demonstrate its application in molecular docking, where it successfully increases the docking score for the generated molecules. The proposed BD-CycleGAN architecture harnesses the power of deep learning to facilitate the generation of molecules with desired structural features, thus offering promising advancements in the field of drug discovery processes.

Persistent organic pollutants (POPs) are ubiquitous and bioaccumulative, posing potential and long-term threats to human health and the ecological environment. Quantitative structure–activity relationship (QSAR) studies play a guiding role in analyzing the toxicity and environmental fate of different organic pollutants. In the current work, five molecular descriptors are utilized to construct QSAR models for predicting the mean and maximum air half-lives of POPs, including specifically the energy of the highest occupied molecular orbital (HOMO_Energy_DMol3), a component of the dipole moment along the z-axis (Dipole_Z), fragment contribution to SAscore (SAscore_Fragments), subgraph counts (SC_3_P), and structural information content (SIC). The QSAR models were achieved through the application of three machine learning methods: partial least squares (PLS), multiple linear regression (MLR), and genetic function approximation (GFA). The determination coefficients (R2) and relative errors (RE) for the mean air half-life of each model are 0.916 and 3.489% (PLS), 0.939 and 5.048% (MLR), 0.938 and 5.131% (GFA), respectively. Similarly, the determination coefficients (R2) and RE for the maximum air half-life of each model are 0.915 and 5.629% (PLS), 0.940 and 10.090% (MLR), 0.939 and 11.172% (GFA), respectively. Furthermore, the mechanisms that elucidate the significant factors impacting the air half-lives of POPs have been explored. The three regression models show good predictive and extrapolation abilities for POPs within the application domain.

COVID-19 can cause different neurological symptoms in some people, including smell, inability to taste, dizziness, confusion, delirium, seizures, stroke, etc. Owing to the issue of vaccine effectiveness, update and coverage, we still need one or more diversified strategies as the backstop to manage illness. Characterizing the structural basis of ligand recognition in the main protease (Mpro) of SARS-CoV-2 will facilitate its rational design and development of potential drug candidates with high affinity and selectivity against COVID-19. Up to date, covalent-, non-covalent inhibitors and allosteric modulators have been reported to bind to different active sites of Mpro. In the present work, we applied the molecular dynamics (MD) simulations to systematically characterize the potential binding features of catalytic active site and allosteric binding sites in Mpro using a dataset of 163 3D structures of Mpro-inhibitor complexes, in which our results are consistent with the current studies. In addition, umbrella sampling (US) simulations were used to explore the dissociation processes of substrate pathway and allosteric pathway. All the information provided new insights into the protein features of Mpro and will facilitate its rational drug design for COVID-19.